| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/24/2003 | US20030139436 Stabilized liquid preparation |
| 07/24/2003 | US20030139433 Incontinence |
| 07/24/2003 | US20030139386 Mixture with surfactants; cannabinol receptor; dietetics |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139383 Respiratory system disorders |
| 07/24/2003 | US20030139382 Method of treating middle ear infections |
| 07/24/2003 | US20030139378 Liquid bisphosphonate formulations for bone disorders |
| 07/24/2003 | US20030139371 Drug for combating sexual dysfunctions |
| 07/24/2003 | US20030139368 Antithrombotic and/or anti-inflammatory composition combining purine activity and NSAID activity |
| 07/24/2003 | US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders |
| 07/24/2003 | US20030139347 Pralmorelin-containing nasal drop preparations |
| 07/24/2003 | US20030139345 Synthetic peptides and methods for treating cancer invasion and metastasis |
| 07/24/2003 | US20030139342 Method of inducing vitreous detachment |
| 07/24/2003 | US20030139340 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 07/24/2003 | US20030139339 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor ( TFPI) |
| 07/24/2003 | US20030139333 Methods and compositions for promoting angiogenesis |
| 07/24/2003 | US20030139326 Antiinflammatory agents; autoimmune disease |
| 07/24/2003 | US20030138936 Spray-dried microbial cells |
| 07/24/2003 | US20030138559 Process for manufacturing a metered dose inhaler |
| 07/24/2003 | US20030138548 Weight management system for obese animals |
| 07/24/2003 | US20030138547 Pet food includes 35-70% by weight protein, 4-10% by weight fat, 5-25% by weight fiber, 10-35% by weight digestible carbohydrate, 0.1-1% by weight functional ingredient to build lean muscle mass |
| 07/24/2003 | US20030138520 Dispersing active ingredients throughout a confectionery product in carrier bodies so the active ingredient can be larger and visible |
| 07/24/2003 | US20030138518 Center-filled chewing gum containing a deliverable form of calcium |
| 07/24/2003 | US20030138508 Method for administering an analgesic |
| 07/24/2003 | US20030138505 Intradermal-penetration agents for topical local anesthetic administration |
| 07/24/2003 | US20030138503 Topical pharmaceutical formulations and methods of treatment |
| 07/24/2003 | US20030138501 A concentrate solution comprising sodium bicarbonate concentrate, electrolyte concentrate; treating renal failure with hemofiltration |
| 07/24/2003 | US20030138499 Stable surgical irrigating solutions |
| 07/24/2003 | US20030138496 Drug delivery system for enhanced bioavailability of hydrophobic active ingredients |
| 07/24/2003 | US20030138495 Drying, evaporating and desolventizing to form the powder; oral administering |
| 07/24/2003 | US20030138494 Topical applying a therapeutic prostaglandins to cause vasodilation, active material dispersed in a gel polymer blends containing an anionic polymer and a nonionic polymer |
| 07/24/2003 | US20030138493 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 07/24/2003 | US20030138492 Devices with coatings containing chlorhexidine gluconate, compositions and methods |
| 07/24/2003 | US20030138491 Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins |
| 07/24/2003 | US20030138490 A controlled-release pharmaceutical drug delivery system comprising active material drug and crosslinkable polymers |
| 07/24/2003 | US20030138489 An aqueous solution comprising of propofol, poloxamers; noncontamination, stability |
| 07/24/2003 | US20030138487 A mixture of particles having different physical and/or chemical properties, for film coating of a drug tablet; non-metal electrodeposition |
| 07/24/2003 | US20030138486 A solid time-release oral medicine comprising a controlled release agent to maintain a low bulk density, for increasing the gastric residence time of the drug |
| 07/24/2003 | US20030138485 Solid at room temperature, water solubility, low viscosity; drugs, foods; a mixture of erythritol, trehalose, xylitol, and maltose |
| 07/24/2003 | US20030138483 The filler contains an alcohol to dissolve the drug and maintain in solution; treating human immunodeficiency virus infections |
| 07/24/2003 | US20030138482 A film-forming composition comprising carrageenan, a bulking agent, plasticizer and water; encapsulating medicinal dosage forms, nutritional supplements, cosmetics, bath oils and gels, and paint balls |
| 07/24/2003 | US20030138481 Liposomes |
| 07/24/2003 | US20030138480 Synthetic fibers for medical use and method of making the same |
| 07/24/2003 | US20030138479 Plaster |
| 07/24/2003 | US20030138474 Have both hydrophilic and hydrophobic blocks; form micelles in aqueous solution, making them suitable for encapsulation or solubilization of hydrophobic or water-insoluble materials; controlled drug delivery |
| 07/24/2003 | US20030138473 First segment comprising a polymerizable matrix and an inorganic filler in contact with first segment, second segment comprising an inorganic material having uniform macro-, meso-and microporosity ; orthopedics, surgery |
| 07/24/2003 | US20030138467 Methods for improving the aesthetic appearance of skin |
| 07/24/2003 | US20030138465 Nanoemulsions comprising at least one amphiphilic lipid, at least one oil, and at least one nonionic polymer, and uses thereof |
| 07/24/2003 | US20030138464 Method and apparatus for improved heat controlled administration of pharmaceuticals |
| 07/24/2003 | US20030138462 Prepared by slurrying pamidronic acid in water, combining with aqueous sodium hydroxide in a 2:1 molar ratio, sealing in unit dosage forms |
| 07/24/2003 | US20030138460 For immobilizing an animal for treatment by administration of botulinum toxin serotype and a polysaccharide stabilizer; veterinary medicine |
| 07/24/2003 | US20030138458 HCV E1E2 vaccine compositions |
| 07/24/2003 | US20030138455 Urogential or anorectal transmucosal vaccine delivery system |
| 07/24/2003 | US20030138453 Microparticles comprise a polymer such as a poly(alpha-hydroxy acid), polyhydroxy butyric acid, polycaprolactone, a polyorthoester, a polyanhydride, formed using cationic, anionic, or nomonic detergents; drug delivery |
| 07/24/2003 | US20030138437 Botulinum toxin and a polysaccharide, such as a hydroxyethyl starch, free of any blood or serum derived proteins, filtrates or fractions useful for diagnostic, therapeutic and/ or research |
| 07/24/2003 | US20030138417 Comprising a succinate of histadine buffer having pH from 5.5-6.5, polysorbate, and a tonicity modifier to contribute to the isotonicity, e.g., NaCl or MgCl2; storage stability of 1-2 years; antiagglomerants |
| 07/24/2003 | US20030138403 Interferon formulations |
| 07/24/2003 | US20030138402 Dry compositions |
| 07/24/2003 | US20030138382 Delivery of caffeine through an inhalation route |
| 07/24/2003 | US20030138381 Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| 07/24/2003 | US20030138369 As an additive in pharmaceutical, food, agricultural, personal care, home care and like products, which increases the disintegration rate of the formed product, and has high oil absorptive properties |
| 07/24/2003 | US20030137067 Compositions having a combination of immediate release and controlled release characteristics |
| 07/24/2003 | US20030136802 Valve for aerosol container |
| 07/24/2003 | CA2651604A1 Method for preparation of substantially amorphous telmisartan |
| 07/24/2003 | CA2474014A1 Pharmaceutical composition comprising 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid |
| 07/24/2003 | CA2473893A1 Stable salts of o-acetylsalicylic acid with basic amino acids ii |
| 07/24/2003 | CA2472579A1 Hiv vaccine and method of use |
| 07/24/2003 | CA2472462A1 Efficient nucleic acid encapsulation into medium sized liposomes |
| 07/24/2003 | CA2472377A1 Crystalline solids of carvedilol and processes for their preparation |
| 07/24/2003 | CA2471960A1 Efficient liposomal encapsulation |
| 07/24/2003 | CA2471918A1 Efficient liposomal encapsulation under mild conditions |
| 07/24/2003 | CA2471483A1 Polytartrate composition |
| 07/24/2003 | CA2470571A1 Povidone-containing carriers for polypeptide growth factors |
| 07/24/2003 | CA2470533A1 Drug nanoparticles from template emulsions |
| 07/24/2003 | CA2470529A1 Medicated tampon |
| 07/24/2003 | CA2470524A1 Use of oligomers and polymers for drug solublization, stabilization, and delivery |
| 07/24/2003 | CA2470520A1 Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient |
| 07/24/2003 | CA2470498A1 Medicinal aerosol compositions with an amide and/or ester containing excipient compound |
| 07/24/2003 | CA2470430A1 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | CA2470413A1 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 07/24/2003 | CA2470400A1 Cultured and encapsulated pancreatic stem cells |
| 07/24/2003 | CA2470293A1 Use of an anti-microtubule agent for the treatment of uveitis |
| 07/24/2003 | CA2469156A1 Center-filled chewing gum containing calcium |
| 07/24/2003 | CA2467764A1 Inorganic nanoparticles to modify the viscosity and physical properties of ophthalmic and otic compositions. |
| 07/24/2003 | CA2464805A1 D-tagatose as an anti-biofilm agent |
| 07/24/2003 | CA2464131A1 Compositions and methods for controlled release |
| 07/24/2003 | CA2440455A1 Bicarbonate-based solutions for dialysis therapies |
| 07/23/2003 | EP1329225A2 Transdermal device containing polyvinylpyrrolidone as solubility enhancer |
| 07/23/2003 | EP1329221A1 Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 07/23/2003 | EP1329218A1 Preventives/remedies for portal hypertension |
| 07/23/2003 | EP1329217A1 Solid preparations |
| 07/23/2003 | EP1328624A2 B7-like molecules and uses thereof |
| 07/23/2003 | EP1328528A1 Pharmaceutical compositions |
| 07/23/2003 | EP1328386A1 Methods of forming shaped articles from suspensions |
| 07/23/2003 | EP1328306A2 Material for producing products having fibrinolytic and/or antibacterial properties |
| 07/23/2003 | EP1328300A1 Self-adhesive hydratable matrix for topical therapeutic use |
| 07/23/2003 | EP1328285A1 Oral preparation containing seaweed for reduction of plaque and calculus |
| 07/23/2003 | EP1328284A1 Novel medicinal herbal composition for treating liver diseases and hiv |
| 07/23/2003 | EP1328280A1 New composition and method for the treatment of dysglucaemia |
| 07/23/2003 | EP1328274A1 Compositions containing an inhibitor of dihydrofolate reductase and a folate |